Adamis Pharmaceuticals Co... (ADMP)
NASDAQ: ADMP
· Real-Time Price · USD
0.78
0.01 (1.50%)
At close: Sep 07, 2023, 9:59 PM
Adamis Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | n/a | -8.57M | -8.94M | -3.33M | -4.4M | -8.4M | -10.35M | -8.77M | -12.36M | -9.31M | -15.38M |
Depreciation & Amortization | n/a | 87.35K | 109.47K | 372K | 398.99K | 368.36K | 344.15K | 363.91K | -253.93K | 678.6K | 647.16K |
Stock-Based Compensation | n/a | 52.2K | 69.29K | -325.96K | 74.49K | -460.92K | 372.12K | 152.5K | 152.56K | 798.07K | 879.77K |
Other Working Capital | n/a | 476.17K | 1.55M | -3.71M | -2.36M | -149.37K | 2M | 1.01M | -5.28M | -8.22M | 587.26K |
Other Non-Cash Items | n/a | 8.1M | 2.26M | 2.75M | -15.76K | -1.73M | 160.83K | 349.12K | 6.51M | 403.14K | 8.16M |
Deferred Income Tax | n/a | -3.91M | n/a | n/a | n/a | -99.87K | -287.63K | -610.13K | 1.26M | 404.69K | 8.16M |
Change in Working Capital | n/a | 1.67M | 4.95M | -988.01K | -3.56M | 424.68K | 2.78M | 1.24M | -3.82M | -9.37M | 1.16M |
Operating Cash Flow | n/a | -2.57M | -1.55M | -1.52M | -7.5M | -9.89M | -6.99M | -6.67M | -9.77M | -16.81M | -4.54M |
Capital Expenditures | n/a | n/a | n/a | -91.49K | -207.76K | -354.24K | -26.93K | -227.18K | -148.44K | -441.64K | -406.19K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 138.29K | 841.78K | 246.8K | 986.98K | 1.37M | 1.56M | 1.39M | 113.81K | n/a | n/a |
Investing Cash Flow | n/a | 138.29K | 841.78K | 155.3K | 779.22K | 1.02M | 1.53M | 1.17M | -34.63K | -441.64K | -406.19K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 750.00 | 2.72M | 284.71M | 285K | n/a | n/a | -42.85K | -2.01M | -24.79K | 56.01M |
Financial Cash Flow | n/a | 750.00 | 2.72M | 284.71M | 285K | n/a | n/a | -42.85K | -2.01M | -24.79K | 56.01M |
Net Cash Flow | n/a | -2.46M | 2.02M | -1.34M | -6.46M | -8.89M | -5.45M | -5.51M | -11.89M | -17.27M | 51.07M |
Free Cash Flow | n/a | -2.57M | -1.55M | -1.61M | -7.71M | -10.25M | -7.01M | -6.9M | -9.92M | -17.25M | -4.94M |